BSEGeneral7 Sept 2026 · 7 Sept 2026, 10:16 pm

Submission of annual report for the financial year ended March 31, 2026.

Novelix Pharmaceuticals Ltd · 536565

✦ AI SummaryResults

Novelix Pharmaceuticals Ltd has submitted its annual report for the financial year ended March 31, 2026, as per the regulatory requirement under Reg. 34 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Novelix Pharmaceuticals Ltd - 536565 - Reg. 34 (1) Annual Report.